Moderna's mRNA Flu Shot Earns FDA Approval After Turbulent Review Process The Food and Drug Administration (FDA) has granted approval to Moderna's mRNA 1010 flu vaccine, a significant milestone in the development of new vaccines using this groundbreaking technology.
However, the journey to this approval was marked by controversy, politicking, and a disturbing trend that threatens public health policy.
Moderna invested heavily in mRNA technology as a means of developing more effective vaccines, and its success with the mRNA 1010 vaccine is a testament to the company's commitment to this approach.